64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

Saved in:

Bibliographic Details
Main Authors:	Rishabh Singh, Ishan J. Tatake, Joseph Sibley, Radhika Gangaraju, Karlyn A. Martin, Rachel P. Rosovsky, Diana Marie Byrnes, Ming Y. Lim, Manila Gaddh, Jacob Cogan, Kimberley Youkhana, Lisa Baumann Kreuziger, Andrew M. Peseski
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925001372
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

POSSIBILITIES OF INHIBITING ANTICOAGULANT ACTIVITIES THAT INHIBIT XA-FACTOR
by: A. D. Erlich
Published: (2019-06-01)

Phenotypic characterization of K2 generation of Peiai64S transgenic rice transformed with Xa21 gene
by: LU Xiao-chun, et al.
Published: (2001-11-01)

56 Analysis of Xa Levels and PTTs During the First 48 Hours of Anticoagulation with Unfractionated Heparin Infusion
by: Kaitlyn Loi
Published: (2025-05-01)

Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation
by: Eva N. Hamulyák, et al.
Published: (2025-02-01)

Investigating interassay variability between direct oral anticoagulant calibrated anti–factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trial
by: Ryan M. Baker, et al.
Published: (2025-05-01)

91 Making It Count: Evaluating an Intervention to Increase Usability of Factor Xa Inhibitor Anti-Xa Levels
by: Emily Tisler, et al.
Published: (2025-05-01)

The Effect of Tapak Liman (Elephantopus scaber L.) Extract on Xa4 Gene Expression in Rice IR64 Infected by Bacterial Leaf Blight (Xanthomonas oryzae)
by: Hardian Susilo Addy, et al.
Published: (2024-02-01)

170 Creation of Patient Self-Managed Warfarin Program Within an Anticoagulation Clinic
by: Julia Kluck, et al.
Published: (2025-05-01)

Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study
by: Maha A.T. Elsebaie, et al.
Published: (2025-05-01)

Hemorrhagic stroke and oral anticoagulants: What is to be done?
by: M. A. Domashenko
Published: (2016-03-01)

PO64 | A silent hemorrhage in the immuno-thrombotic chaos of antiphospholipid syndrome
Published: (2025-08-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Oral anticoagulant therapy in patients after intracerebral hemorrhage
by: A. A. Kulesh, et al.
Published: (2020-06-01)

PO13 | Monitoring of anti-factor XA activity levels in patients treated with direct oral anticoagulants and concomitant tyrosine kinase inhibitors agents: a monocentric experience
Published: (2025-08-01)

Sự phản xạ và khúc xạ của sóng SH đối với lớp có biến dạng ban đầu không thuần nhất
by: Pham Chi Vinh
Published: (1986-09-01)

Spontaneous suprachoroidal hemorrhage due to the excessive anticoagulation therapy. Case report
by: A. Stepanov,, et al.
Published: (2014-07-01)

Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
by: Alok Dabi, et al.
Published: (2018-01-01)

Efficient Marker-Assisted Pyramiding of <i>Xa21</i> and <i>Xa23</i> Genes into Elite Rice Restorer Lines Confers Broad-Spectrum Resistance to Bacterial Blight
by: Yao Li, et al.
Published: (2025-07-01)

Pediatricians 64
by: Alexander S. Sozinov
Published: (2021-03-01)

Creation of gene-specific rice mutants by AvrXa23-based TALENs
by: Fu-jun WANG, et al.
Published: (2017-02-01)

DEVELOPMENT, VALIDATION AND APPLICATION OF ANTI-Xa- AND ANTI-IIa-ENOXAPARINE SODIUM ASSAY
by: B. Yu. Margaeva, et al.
Published: (2019-01-01)

Condition Numbers of the Nonlinear Matrix Equation Xp-A⁎eXA=I
by: Chacha Stephen Chacha, et al.
Published: (2018-01-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?
by: Ali Zalpour, et al.
Published: (2011-01-01)

Occurrence of hemorrhagic events related to invasive devices manipulated by nursing in anticoagulated patients
by: Flavia Giron Camerini, et al.
Published: (2017-09-01)

Occurrence of hemorrhagic events related to invasive devices manipulated by nursing in anticoagulated patients
by: Flavia Giron Camerini, et al.
Published: (2017-09-01)

Adrenocortical insufficiency after bilateral adrenal hemorrhage due to anticoagulation and chronic immunothrombocytopenia
by: Sophie Charlotte Hintze, et al.
Published: (2024-11-01)

Isolated Central Sulcus Hemorrhage: A Rare Presentation Most Frequently Associated with Cerebral Amyloid Angiopathy
by: Murthy R. Chamarthy, et al.
Published: (2012-01-01)

Establishment and validation of a method for determining anti-Xa factor potency of enoxaparin sodium
by: En Zhang, et al.
Published: (2025-05-01)

Parâmetros de diagnóstico de dentes extensamente destruídos em prostodontia fi xa
by: C. Matos, et al.
Published: (2008-12-01)

Direct Oral Anticoagulant Use and Risk of Diverticular Hemorrhage: A Systematic Review of the Literature
by: MacKenzie Turpin, et al.
Published: (2019-01-01)

Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
by: E. V. Titaeva, et al.
Published: (2020-12-01)

Plasma levels of direct Xa inhibitors apixaban and rivaroxaban in patients with venous thromboembolism in clinical practice
by: I. Paskaleva, et al.
Published: (2025-05-01)

Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients
by: Pavlović Svetlana, et al.
Published: (2007-01-01)

The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data
by: Kyle M. Ware, et al.
Published: (2017-01-01)

Laboratory Predictors of Hemorrhagic Complications in Patients With Total Hip Arthroplasty and Treatment With Direct Oral Anticoagulants
by: L. B. Gaikovaya, et al.
Published: (2023-11-01)

Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database.
by: Tsuyoshi Nakai, et al.
Published: (2025-01-01)

Editorial du numéro 64
by: Sébastien Velut, et al.
Published: (2024-10-01)

About the 64th issue,
by: Ayşen Akkor Gül
Published: (2023-06-01)

90 Evaluation of a Protocol For Heparin Initiation in Patients Transitioning from Oral Factor Xa Inhibitors
by: Carla E. Staresinic, et al.
Published: (2025-05-01)